Neurofibromatosis-Noonan syndrome: Molecular evidence of the concurrence of both disorders in a patient
- 30 July 2005
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 136A (3), 242-245
- https://doi.org/10.1002/ajmg.a.30813
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activationHuman Mutation, 2004
- Different mutations in theNF1gene are associated with Neurofibromatosis–Noonan syndrome (NFNS)American Journal of Medical Genetics Part A, 2003
- Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndromeHuman Genetics, 2002
- Grouping of Multiple-Lentigines/LEOPARD and Noonan Syndromes on the PTPN11 GeneAmerican Journal of Human Genetics, 2002
- Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndromeAmerican Journal of Medical Genetics, 1998
- The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2JAMA, 1997
- Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis associationAmerican Journal of Medical Genetics, 1996
- Mapping a gene for Noonan syndrome to the long arm of chromosome 12Nature Genetics, 1994
- The Genetic Aspects of NeurofibromatosisaAnnals of the New York Academy of Sciences, 1986
- Noonan phenotype associated with neurofibromatosisAmerican Journal of Medical Genetics, 1985